Association of metabolic syndrome with microalbuminuria in hypertension


  • Palida Nongnuan School of Nursing, Walailak University
  • Jom Suwanno School of Nursing, Walailak University
  • Chennet Phonnphet School of Nursing, Walailak University


Microalbuminuria, Metabolic Syndrome, Hypertension


     This cross-sectional survey research is aimed to look into the relationship between metabolic syndrome and urinary microalbumin leakage in hypertensive patients visiting 4 Subdistrict Health Promotion Hospitals in Nakhon Si Thammarat, totaling 284 patients. Data were analyzed using statistics Chi-square test, Logistic Regression Equation with the risk ratio, and a Confidence Interval of 95 percent.

     The results showed that most of the research samples were female, accounting for 76.41 percent, with a mean age of 65.70 years. 86.50 percent of hypertensive patients were found to have microalbumin leakage in the urine. The multivariate analysis revealed a group of factors associated with urinary microalbumin leakage with statistical significance. when adjusting for extraneous variables, gender and age was a group of factors of high blood pressure, obesity, and hyperglycemia, (Adjusted OR = 2.57, 95%CI: 1.18-5.61)

     This study suggested that hypertensive patients with metabolic syndrome, hyperglycemia, and, obesity should be administered Microalbumin screening and metabolic factor assessment as well as obese patients to reduce the risk of cardiovascular diseases comprehensively.


Download data is not yet available.


Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Parodi D, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J. Intern. Med. 2005; 257(5): 454-60.

Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003; 16(11): 952-8.

Choi HS, Ryu SH, Lee KB. The relationship of microalbuminuria with metabolic syndrome. Nephron Clin Pract. 2006; 104(2): c85–93. doi:10.1159/000093995.

Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia. 2000; 43(11): 1397-403.

Chen J, Kong X, Jia X, Li W, Wang Z, Cui M, et al. Association between metabolic syndrome and chronic kidney disease in a Chinesurban population. Clinica Chimica Acta. 2017; 470: 103-8.

Hao Z, Konta T, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Intern med. 2007; 46(7): 341-6.

Sheng CS, Hu BC, Fan WX, Zou J, Li Y, Wang JG. Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetes Metab Syndr. 2011; 3(6): doi:10.1186/1758-5996-3-6.

Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clinica Chimica Acta. 2010; 411(9-10): 705–9.

Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest. 2007; 37(10): 783–90.

Yoshizumi M, Abe JI, Tsuchiya K, Berk BC, Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cell: Possible role of mitogen-activated protein kinases. J Phamacol Sci. 2003; 91: 172-6.

Tsilibary EC. Microvascular basement membranes in diabetes mellitus. J Pathol. 2003; 200: 537-46.

Yamane T. Statistics an introductory analysis. 2nd Edition, New York: Harper and Row; 1967.

Huang PL. A comprehensive definition for metabolic syndrome. Dis. Models Mech. 2009; 2: 231-37.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17): 2735-52.

The Kidney Disease: Improving Global Outcomes Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Int Soc Nephrol. 2013; 3(1): 1-136.

Ochodnicky P, Henning PH, van Dokkum RPE, de Zeeuw D. Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage. J. Cardiovasc. Pharmacol. 2006; 47(2): 151-62.

Volpe M, Battistoni A, Tocci G, Rosei EA, Catapano AL, Coppo R, et al. Cardiovascular risk assessment beyond systemic coronary risk estimation: A role for organ damage markers. Hypertension. 2012; 30(6): 1056-64.

Habbal R, Sekhri AR, Volpe M. Prevalence of microalbuminuria in hypertensive patients and its associated cardiovascular risk in clinical cardiology: Moroccan results of the global i-sEarCh survey a sub-analysis of a survey with 21,050 patients in 26 countries worldwide. Cardiovasc J Afr. 2010; 21(4): 200-5.

Lee YY, Yang CK, Weng YM, Chuang CH, Yu W, Chen JC, et al. All components of metabolic syndrome are associated with microalbuminuria in a Chinese population. PLoS ONE. 2016; 11(6): doi:10.1371/journal. pone.0157303.





Research Articles